ES2935705T3 - Un ligando del receptor GABA A - Google Patents

Un ligando del receptor GABA A Download PDF

Info

Publication number
ES2935705T3
ES2935705T3 ES19765747T ES19765747T ES2935705T3 ES 2935705 T3 ES2935705 T3 ES 2935705T3 ES 19765747 T ES19765747 T ES 19765747T ES 19765747 T ES19765747 T ES 19765747T ES 2935705 T3 ES2935705 T3 ES 2935705T3
Authority
ES
Spain
Prior art keywords
compound
gaba
treatment
rats
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES19765747T
Other languages
English (en)
Spanish (es)
Inventor
Janus Larsen
Dipak Amrutkar
Thomas Jacobsen
Tino Dyhring
Karin Nielsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Saniona AS
Original Assignee
Saniona AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saniona AS filed Critical Saniona AS
Application granted granted Critical
Publication of ES2935705T3 publication Critical patent/ES2935705T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES19765747T 2018-09-13 2019-09-13 Un ligando del receptor GABA A Active ES2935705T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18194297 2018-09-13
PCT/EP2019/074465 WO2020053377A1 (en) 2018-09-13 2019-09-13 A gabaa receptor ligand

Publications (1)

Publication Number Publication Date
ES2935705T3 true ES2935705T3 (es) 2023-03-09

Family

ID=63579205

Family Applications (1)

Application Number Title Priority Date Filing Date
ES19765747T Active ES2935705T3 (es) 2018-09-13 2019-09-13 Un ligando del receptor GABA A

Country Status (24)

Country Link
US (1) US11396510B2 (cg-RX-API-DMAC7.html)
EP (1) EP3849976B1 (cg-RX-API-DMAC7.html)
JP (1) JP7353663B2 (cg-RX-API-DMAC7.html)
KR (1) KR102712565B1 (cg-RX-API-DMAC7.html)
CN (1) CN112714765B (cg-RX-API-DMAC7.html)
AU (1) AU2019338236B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021004661A2 (cg-RX-API-DMAC7.html)
CA (1) CA3110283A1 (cg-RX-API-DMAC7.html)
DK (1) DK3849976T3 (cg-RX-API-DMAC7.html)
EA (1) EA202190717A1 (cg-RX-API-DMAC7.html)
ES (1) ES2935705T3 (cg-RX-API-DMAC7.html)
FI (1) FI3849976T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20230067T1 (cg-RX-API-DMAC7.html)
HU (1) HUE060943T2 (cg-RX-API-DMAC7.html)
IL (1) IL281335B2 (cg-RX-API-DMAC7.html)
LT (1) LT3849976T (cg-RX-API-DMAC7.html)
MX (1) MX2021003010A (cg-RX-API-DMAC7.html)
PH (1) PH12021550299A1 (cg-RX-API-DMAC7.html)
PL (1) PL3849976T3 (cg-RX-API-DMAC7.html)
PT (1) PT3849976T (cg-RX-API-DMAC7.html)
SG (1) SG11202101360VA (cg-RX-API-DMAC7.html)
SI (1) SI3849976T1 (cg-RX-API-DMAC7.html)
WO (1) WO2020053377A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202100976B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240197733A1 (en) 2021-04-16 2024-06-20 Saniona A/S A gaba receptor modulator for use in the treatment of pain
EP4777104A1 (en) * 2023-09-15 2026-07-22 Saniona A/S A gaba receptor modulator for treating disorders associated with sleep spindle deficits
EP4777103A1 (en) * 2023-09-15 2026-07-22 Saniona A/S A gaba receptor modulator for use in the treatment of absence seizures
WO2026109691A1 (en) * 2024-11-22 2026-05-28 Saniona A/S A gaba receptor modulator for use in the treatment of tremor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU675484B2 (en) 1993-03-24 1997-02-06 Neurosearch A/S Benzimidazole compounds, their use and preparation
GB9702524D0 (en) 1997-02-07 1997-03-26 Merck Sharp & Dohme Therapeutic agents
GB9813576D0 (en) * 1998-06-24 1998-08-19 Merck Sharp & Dohme Therapeutic agents
JP2002535407A (ja) * 1999-01-27 2002-10-22 メルク シャープ エンド ドーム リミテッド Gaba受容体のリガンドとしてのトリアゾロピリダジン誘導体
GB9921150D0 (en) 1999-09-07 1999-11-10 Merck Sharp & Dohme Therapeutic agents
GB0208394D0 (en) * 2002-04-11 2002-05-22 Merck Sharp & Dohme Therapeutic agents
GB0208392D0 (en) * 2002-04-11 2002-05-22 Merck Sharp & Dohme Therapeutic compounds
GB0212048D0 (en) 2002-05-24 2002-07-03 Merck Sharp & Dohme Therapeutic agents
MXPA05010449A (es) 2003-04-03 2006-05-31 Neurosearch As Derivados del bencimidazol y su uso para modular el complejo del receptor de gabaa.
TWI391381B (zh) * 2006-03-24 2013-04-01 Neurosearch As 新穎的苯并咪唑衍生物、含有其之醫藥組成物、及其於製造藥物之用途
TW201029986A (en) 2008-11-14 2010-08-16 Neurosearch As Novel compounds
BR112018015386A2 (pt) 2016-01-27 2019-03-19 Universität Zürich uso de moduladores de receptor gabaa para tratamento de prurido

Also Published As

Publication number Publication date
LT3849976T (lt) 2023-02-10
EP3849976A1 (en) 2021-07-21
PT3849976T (pt) 2023-01-13
US11396510B2 (en) 2022-07-26
HUE060943T2 (hu) 2023-04-28
EA202190717A1 (ru) 2021-09-22
DK3849976T3 (da) 2023-01-23
FI3849976T3 (fi) 2023-02-19
WO2020053377A1 (en) 2020-03-19
CA3110283A1 (en) 2020-03-19
PL3849976T3 (pl) 2023-02-27
IL281335A (en) 2021-04-29
CN112714765A (zh) 2021-04-27
MX2021003010A (es) 2021-05-27
BR112021004661A2 (pt) 2021-06-01
KR102712565B1 (ko) 2024-10-02
CN112714765B (zh) 2023-06-30
SG11202101360VA (en) 2021-03-30
IL281335B1 (en) 2024-03-01
ZA202100976B (en) 2022-08-31
JP2022500445A (ja) 2022-01-04
US20210332042A1 (en) 2021-10-28
HRP20230067T1 (hr) 2023-03-17
PH12021550299A1 (en) 2021-10-25
IL281335B2 (en) 2024-07-01
AU2019338236B2 (en) 2025-01-09
SI3849976T1 (sl) 2023-03-31
JP7353663B2 (ja) 2023-10-02
EP3849976B1 (en) 2022-10-26
KR20210061338A (ko) 2021-05-27
AU2019338236A1 (en) 2021-05-20

Similar Documents

Publication Publication Date Title
ES2938546T3 (es) Método de tratamiento de la esclerosis lateral amiotrófica con pridopidina
ES2791539T3 (es) Compuestos para el tratamiento de enfermedades relacionadas con la expresión de DUX4
US20100178277A1 (en) Methods and compositions for stimulating cells
TWI791507B (zh) 使用ccr3-抑制劑治療老化相關損傷之方法及組合物
ES2733929T3 (es) Una combinación farmacéutica para el tratamiento del melanoma
AU2019338236B2 (en) A GABAA receptor ligand
JP6640725B2 (ja) spadinのレトロ−インベルソ類似体は増大された抗うつ作用を示す
RU2341261C2 (ru) Композиции, содержащие эпотилоны, и их применение для лечения карциноидного синдрома
US10709687B2 (en) FLT3 receptor inhibitor at low dosage for the treatment of neuropathic pain
ES2815555T3 (es) Triple combinación de antagonistas del receptor 5-HT6 puros, inhibidores de la acetilcolinesterasa y antagonista del receptor NMDA
JP6889493B2 (ja) 脳卒中からの回復のための方法および組成物
ES2796181T3 (es) Combinación de antagonistas puros del receptor 5-HT6 con inhibidores de acetilcolinesterasa
KR20100051837A (ko) 소아 종양의 치료
EP3782620B1 (en) Pharmaceutical composition comprising 1,2-naphthoquinone derivative for use in preventing or treating acute myeloid or lymphoblastic leukemia
ES2808667T3 (es) Derivados de diarilmetilideno piperidina y su uso como agonistas del receptor opioide delta
BR112021004938A2 (pt) métodos e composições para tratamento de danos associados com o envelhecimento usando inibidores de ccr3
HK40057209B (en) A gabaa receptor ligand
HK40057209A (en) A gabaa receptor ligand
ES2930974T3 (es) Compuesto (8ar, 12as, 13as) -5,8,8a, 9,10,11,12,12a,13,13a-decahidro-3-metoxi-12-(etilsulfonil)-6h-isoquino [2,1-g] [1,6] naftiridina para su uso en el tratamiento de psicosis
WO2025229051A1 (en) Use of atr inhibitors in combination with antiandrogen agent
ES3062815T3 (en) Compositions for treating aging-associated impairments using ccr3-inhibitors
BR112023024140B1 (pt) Uso de uma superóxido dismutase lecitinizada para tratar ou prevenir um distúrbio associado com a administração de um agente anticâncer
WO2012009823A1 (es) Formulación farmaceutica tranquilizante/sedante a base de neuroesteroides y un derivado fenotiazínico para uso en mamiferos
Deshpande Application of a sedation scoring system in dogs following premedication: thesis is submitted by Deepti Deshpande to fulfil the requirements for the degree of Masters of Veterinary Studies in the Institute of Veterinary, Animal and Biomedical Sciences, College of Sciences, Massey University, Palmerston North, New Zealand